Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

By Y. Shaked, A. Ciarrocchi, Marcela Franco, Christina R. Lee, S. Man, Alison Cheung, D. Hicklin, D. Chaplin, F. S. Foster, R. Benezra and 1 more. Science, 2006

602 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/ed81c2d187322a055abb707819ca756ccfdce1bd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. J. Pollard
2. J. Joyce
3. N. Vasudev
4. Andrew R Reynolds
5. R. Kerbel

In Molecular Biology

1. J. Joyce
2. N. Vasudev
3. Andrew R Reynolds
4. P. Mancuso
5. F. Bertolini
6. Y. Shaked
7. J. Pollard
8. R. Kerbel

In Oncology

1. J. Joyce
2. J. Pollard
3. P. Mancuso
4. F. Bertolini
5. Y. Shaked
6. N. Vasudev
7. Andrew R Reynolds
8. R. Kerbel

Citations in the corpus

• Microenvironmental regulation of metastasis (2009, background): “Resistance to these drugs can be overcome in part through anti-VEGFR2 blocking antibodies, or by genetic ablation of EPCs in ID1 and ID3-deficient mic”
• Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions (2014, background): “Preclinical studies have demonstrated that infiltration of tumours by various stromal cell types, including immature myeloid cells [158, 159], endothelial progenitor cells [160] or fibroblasts [141] can all mediate resistance to VEGF-targeted agents in preclinical models (Fig.”
• The multifaceted circulating endothelial cell in cancer: towards marker and target identification (2006, methodology): “An example of this was recently reported by Shaked et al”